Hasija Amit 4

4 · Milestone Pharmaceuticals Inc. · Filed Feb 4, 2026

AI-generated summary of this filing

Updated Feb 4, 2026

Milestone (MIST) CFO Amit Hasija Receives Equity Awards

What Happened

Amit Hasija, Chief Financial Officer and EVP of Corporate Development at Milestone Pharmaceuticals (MIST), was granted two equity awards on February 2, 2026: 204,000 derivative awards (option-type) and 136,000 restricted stock units (RSUs). Both grants show $0.00 per share (no cash paid at grant). Total awards = 340,000 shares.

Key Details

Transaction date: February 2, 2026; filing date: February 4, 2026 (filed timely).
Grant types: two "A" (award/grant) transactions — 204,000 derivative/option-style awards and 136,000 RSUs.
Price: reported as $0.00 per share for both grants (no cash outlay at grant).
Shares owned after transaction: not disclosed in this Form 4 filing.
Vesting / footnotes:
- Option-style award vesting (F1): 1/4 vests on Feb 2, 2027, then 1/36 of the remaining shares vest each month thereafter, subject to continued service.
- RSU meaning (F2): each RSU converts to one common share if vested.
- RSU vesting (F3): 1/4 vests each year on Feb 2 of 2027, 2028, 2029 and 2030, subject to continued service.
No 10b5-1 plan, tax withholding sale, or late-filing indication noted.

Context

These are compensation awards, not open-market purchases or sales. Grants like these are common for executive pay and are intended for retention; they do not indicate an immediate buy or sell of shares. Because the awards vest over time, Hasija will only acquire shares if she remains employed and the awards vest per the schedules above.

Form 4

Period: 2026-02-02

CFO & EVP of Corp. Development

Transactions

Award
Employee Stock Option (right to buy)
[F1]
2026-02-02+204,000→ 204,000 total
Exercise: $1.97Exp: 2036-02-02→ Common Shares (204,000 underlying)
Award
Restricted Stock Unit
[F2][F3]
2026-02-02+136,000→ 136,000 total
→ Common Shares (136,000 underlying)

Footnotes (3)

[F1]One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
[F2]Each restricted stock unit represents a contingent right to receive one common share.
[F3]One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date.

Signature

/s/ Joseph Oliveto, Attorney-in-Fact|2026-02-04

1 file